Frequency of serious adverse events on therapy with modified fully oral shorter treatment regimens (mSTR) for MDR/RR-TB
Conclusion: SAE occur during mSTR, but rarely lead to treatment discontinuation. Proper SAE monitoring and management are essential for any TB response.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Gurbanova, E., Yatskevich, N., Yedilbayev, A., Korotych, O., Hovhannesyan, A., Tyshko, M., Dankova, N., Skrahina, A. Tags: Tuberculosis and non-tuberculous mycobacterial diseases Source Type: research
More News: Bedaquiline | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cardiology | COVID-19 | Encephalitis | Heart | Heart Failure | Hemorrhagic Stroke | Levaquin | Linezolid | Neurology | Oral Cancer | Respiratory Medicine | Tuberculosis | Zyvox